Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1993-02-04
1994-08-23
Cintins, Marianne M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514212, 514213, 514381, 514397, 514406, 514444, 514468, 514438, 514649, 514650, 514415, A61K 3144, A61K 3155, A61K 3138, A61K 3134
Patent
active
053408268
ABSTRACT:
The present invention relates to a method of treating or preventing urinary incontinence in mammals, including humans, using certain quinuclidine derivatives, piperidine derivatives, azanorbornane derivatives and related compounds.
REFERENCES:
patent: 4645758 (1987-02-01), Willman et al.
patent: 5089505 (1992-02-01), Alker et al.
patent: 5106851 (1992-04-01), Turconi et al.
patent: 5219871 (1993-06-01), Cross et al.
patent: 5231104 (1993-07-01), Alker et al.
patent: 5236956 (1993-08-01), Sjogren et al.
Desai Manoj C.
Lowe, III John A.
Rosen Terry J.
Cintins Marianne M.
Criares T. J.
DeBenedictis Karen
Ginsburg Paul H.
Pfizer Inc.
LandOfFree
Pharmaceutical agents for treatment of urinary incontinence does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical agents for treatment of urinary incontinence, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical agents for treatment of urinary incontinence will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-503305